Scott Adams Seeks Trump's Aid as Kaiser Permanente Delays FDA-Approved Pluvicto Treatment

Image for Scott Adams Seeks Trump's Aid as Kaiser Permanente Delays FDA-Approved Pluvicto Treatment

Scott Adams, the acclaimed creator of the "Dilbert" comic strip, has publicly announced his intention to appeal to former President Donald Trump for assistance in securing urgent cancer treatment. Adams, who is battling metastatic prostate cancer, stated his healthcare provider, Kaiser of Northern California, has approved his treatment with the FDA-approved drug Pluvicto but has failed to schedule its administration. He plans to make this plea to President Trump via the social media platform X on Monday.

Adams revealed his health is rapidly declining due to the delay in receiving the crucial treatment. He indicated that President Trump had previously offered to help him if needed, and he now considers that need to be immediate. > "My healthcare provider, Kaiser of Northern California, has approved my application to receive a newly FDA-approved drug called Pluvicto. But they have dropped the ball in scheduling the brief IV to administer it and I can’t seem to fix that," Adams stated in his tweet.

Pluvicto (lutetium Lu 177 vipivotide tetraxetan) is an FDA-approved radioligand therapy specifically designed for PSMA-positive metastatic castration-resistant prostate cancer (mCRPC). This targeted treatment has demonstrated significant efficacy in clinical trials, offering eligible patients extended survival and improved quality of life. While Adams noted it is "not a cure," he emphasized that it "does give good results to many people."

The cartoonist's urgent appeal highlights broader concerns regarding healthcare access and treatment delays within large medical systems. Kaiser Permanente, particularly in California, has faced scrutiny and accusations in recent times for alleged delays in various forms of patient care, including cancer treatments and mental health services. These reports suggest a systemic issue that can significantly impact patient outcomes.

Adams' decision to seek intervention from a high-profile figure like Donald Trump underscores the critical nature of his situation and his perceived inability to resolve the scheduling issue through conventional channels. He hopes Trump's involvement will prompt Kaiser of Northern California to act swiftly. > "I will ask President Trump if he can get Kaiser of Northern California to respond and schedule it for Monday. That will give me a fighting chance to stick around on this planet a little bit longer," Adams conveyed in his social media post.